2006

This question was explored by panelists partici-pating in this month's Pharma Marketing Roundtable conference call, which was focused on pharmaceutical industry support of CME.

There's blood in the water and ad agencies are circlingbiotech companies, trying to entice them into transforming themselves into marketing machines. Some agency people suggest that biotech needs to engage in traditional direct-to-consumer (DTC) advertising. Biotech, however, needs more than DTC as usual.

This article is based on an interview with Rost, Pharma's Black Knight.

This article is based on an interview with Rost, Pharma's Black Knight.

One poll says the pharma industry is doing a good job, another says it can't be trusted. What's up with that?

This article is an edited transcript of the May 2006, Pharma Marketing Roundtable discussion, which was devoted to exploring issues surrounding the new roles of medical science liaisons (MSLs) and key opinion leader physicians (KOLs) in physician education and product marketing.

Vol. 5, No. 5: May 2006 - EXECUTIVE SUMMARY Welcome to the latest issue of Pharma Marketing News. This is the Executive Summary version....

This article is an edited transcript of the May 2006, Pharma Marketing Roundtable discussion, which was devoted to exploring issues surrounding the new roles of medical science liaisons (MSLs) and key opinion leader physicians (KOLs) in physician education and product marketing.

This article presents a lightly edited transcript of a Pharma Marketing Roundtable discussion of the March 31, 2006 Coalition for Healthcare Communication's Citizens Petition to the FDA seeking new prescription drug advertising rules to simply the communication of risk information in DTC ads.

Pharma Marketing Network hosted an online survey asking respondents' opinions regarding the the Coalition for Healthcare Communication's petition to the FDA.